Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Havrix long-term antibody persistence (Years 11-20)
NCT00291876Phase 4Completed
- Sponsor
- GSK
- Start
- Jan 2004
- Primary completion
- Mar 2013
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of Hepatitis A virus vaccine in hepatitis A (HAV), sponsored by GSK. Started Jan 2004; status: completed.
02
Drugs
Hepatitis A virus vaccine
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT00291876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00291876.